CA2806198C - Silver oxide formulations having improved whiteness characteristics - Google Patents

Silver oxide formulations having improved whiteness characteristics Download PDF

Info

Publication number
CA2806198C
CA2806198C CA2806198A CA2806198A CA2806198C CA 2806198 C CA2806198 C CA 2806198C CA 2806198 A CA2806198 A CA 2806198A CA 2806198 A CA2806198 A CA 2806198A CA 2806198 C CA2806198 C CA 2806198C
Authority
CA
Canada
Prior art keywords
oxide
silver
zinc oxide
formulation
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2806198A
Other languages
English (en)
French (fr)
Other versions
CA2806198A1 (en
Inventor
Perry Antelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aidance Skincare and Topical Solutions LLC
Original Assignee
Aidance Skincare and Topical Solutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aidance Skincare and Topical Solutions LLC filed Critical Aidance Skincare and Topical Solutions LLC
Publication of CA2806198A1 publication Critical patent/CA2806198A1/en
Application granted granted Critical
Publication of CA2806198C publication Critical patent/CA2806198C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2806198A 2009-07-21 2010-07-21 Silver oxide formulations having improved whiteness characteristics Active CA2806198C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22729709P 2009-07-21 2009-07-21
US61/227,297 2009-07-21
GB1003870.1 2010-03-09
GB1003870A GB2472126B (en) 2009-07-21 2010-03-09 Topical Formulations Containing Silver (II) Oxide and Zinc Oxide
PCT/IB2010/002024 WO2011010221A1 (en) 2009-07-21 2010-07-21 Silver oxide formulations having improved whiteness characteristics

Publications (2)

Publication Number Publication Date
CA2806198A1 CA2806198A1 (en) 2011-01-27
CA2806198C true CA2806198C (en) 2018-02-13

Family

ID=42136680

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2806198A Active CA2806198C (en) 2009-07-21 2010-07-21 Silver oxide formulations having improved whiteness characteristics

Country Status (11)

Country Link
US (1) US8647647B2 (https=)
EP (1) EP2456447B1 (https=)
JP (1) JP5883785B2 (https=)
KR (1) KR101807885B1 (https=)
CN (1) CN102470148B (https=)
AU (1) AU2010274654B2 (https=)
CA (1) CA2806198C (https=)
GB (1) GB2472126B (https=)
IL (1) IL217660A (https=)
WO (1) WO2011010221A1 (https=)
ZA (1) ZA201200963B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10391124B2 (en) 2009-07-21 2019-08-27 Aidance Skincare & Topical Solutions Llc Silver oxide formulations
GB2487438B8 (en) * 2011-01-24 2014-08-06 Aidance Skincare & Topical Solutions Llc Stable silver oxide formulations
US9687509B2 (en) * 2009-11-06 2017-06-27 Aidance Skincare And Topical Solutions, Llc Silver oxide formulations
US20130189372A1 (en) * 2010-02-06 2013-07-25 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
CN106211756B (zh) * 2014-01-27 2019-12-27 帮助护肤及局部解决方案公司 局部用抗生素制剂
TW201630994A (zh) * 2015-02-08 2016-09-01 阿爾賈曼技術有限公司 使用於安全面罩及個人防護衣物的抗微生物織物材料
CN107207771B (zh) 2015-02-08 2019-12-06 阿尔贾曼技术有限公司 包含金属氧化物的协同组合的抗微生物材料
US11224227B2 (en) 2015-02-08 2022-01-18 Argaman Technologies Ltd. Antimicrobial material comprising synergistic combinations of metal oxides
TWI754608B (zh) * 2015-02-08 2022-02-11 以色列商阿爾賈曼技術有限公司 包含金屬氧化物之協同組合的皮膚再生材料
CZ2018477A3 (cs) * 2018-09-17 2020-04-29 Ĺ KODA AUTO a.s. Soustava pro upevnění prosvětlené masky chladiče
DE102024111212A1 (de) * 2024-04-22 2025-10-23 Boehm Medical Protection GmbH Dermale pharmazeutische Zusammensetzung

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2521713A (en) * 1945-07-23 1950-09-12 Sunshine Mining Company Method for producing a microbicidal composition of matter
US4489223A (en) * 1982-07-28 1984-12-18 Smart Start Corporation Battery jump cable apparatus
ATE88324T1 (de) * 1984-12-28 1993-05-15 Johnson Matthey Plc Antimikrobielle zusammensetzungen.
JPH02268104A (ja) * 1989-04-07 1990-11-01 Kanebo Ltd 抗菌性組成物
EP0427858A4 (en) * 1989-02-28 1993-03-10 Kanebo Ltd. Antibacterial or conductive composition and applications thereof
JPH02265605A (ja) * 1989-04-06 1990-10-30 Tetsuo Nishida 固液分離装置
US5336499A (en) 1992-01-10 1994-08-09 Antelman Technologies, Ltd. Molecular crystal device for pharmaceuticals
US6258385B1 (en) 1999-04-22 2001-07-10 Marantech Holding, Llc Tetrasilver tetroxide treatment for skin conditions
US6485755B1 (en) 2000-01-06 2002-11-26 Marantech Holding Methods of using electron active compounds for managing cancer
US6669966B1 (en) 2000-01-06 2003-12-30 Marantech Holding Llc Compositions for facilitating skin growth and methods and articles using same
US6645531B1 (en) 2000-01-06 2003-11-11 Marantech Holding Llc Multivalent electron active compositions and methods of making and using same
US20060105057A1 (en) * 2000-01-06 2006-05-18 Marantech Holding, Llc Compositions using tetrasilver tetroxide and methods for management of skin conditions using same
WO2001049302A1 (en) * 2000-01-06 2001-07-12 Marantech Holding, Llc Compositions and methods for facilitating skin growth and managing skin conditions
US20040247696A1 (en) 2001-07-05 2004-12-09 Antelman Marvin S. Methods of using electron active compounds for managing conditions afflicting mammals
KR20060015514A (ko) * 2003-04-18 2006-02-17 메르크 파텐트 게엠베하 항미생물 안료
US20060017197A1 (en) * 2004-07-20 2006-01-26 Christensen Donald J Coring of compression-molded phenolic
CN100394986C (zh) * 2004-11-09 2008-06-18 深圳市源兴生物医药科技有限公司 一种含银锌组合物的创伤敷料
CN1778313A (zh) * 2004-11-22 2006-05-31 深圳市清华源兴生物医药科技有限公司 一种防治皮肤浅部真菌感染和妇女生殖道感染的药物
US20060171971A1 (en) * 2005-02-01 2006-08-03 The Procter & Gamble Company Composition for wet wipes containing a non-irritating skin health benefit ingredient and the process for making
WO2007000591A2 (en) 2005-06-27 2007-01-04 Smith & Nephew, Plc Antimicrobial materials
US20080014278A1 (en) * 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
EP2112882A2 (en) * 2007-01-23 2009-11-04 Merck Patent GmbH Antimicrobial composition comprising zinc oxide, barium sulphate and silver ions
US8894980B2 (en) * 2007-11-19 2014-11-25 U.S. Cosmetics Corporation Wet cake composition for cosmetic products and methods of use

Also Published As

Publication number Publication date
GB201003870D0 (en) 2010-04-21
US8647647B2 (en) 2014-02-11
AU2010274654A1 (en) 2012-02-23
JP2012533614A (ja) 2012-12-27
EP2456447A1 (en) 2012-05-30
ZA201200963B (en) 2013-05-29
CA2806198A1 (en) 2011-01-27
JP5883785B2 (ja) 2016-03-15
WO2011010221A1 (en) 2011-01-27
CN102470148A (zh) 2012-05-23
AU2010274654B2 (en) 2016-04-28
KR101807885B1 (ko) 2017-12-11
CN102470148B (zh) 2015-04-01
GB2472126A (en) 2011-01-26
IL217660A (en) 2016-02-29
EP2456447A4 (en) 2013-01-02
US20110020468A1 (en) 2011-01-27
KR20120037017A (ko) 2012-04-18
EP2456447B1 (en) 2016-08-24
GB2472126B (en) 2011-08-03

Similar Documents

Publication Publication Date Title
CA2806198C (en) Silver oxide formulations having improved whiteness characteristics
KR100929469B1 (ko) 항균 제제
Vianna et al. Efficacy of sodium hypochlorite combined with chlorhexidine against Enterococcus faecalis in vitro
DE69921867T2 (de) Mikrobizide Zusammensetzung
US20090246292A1 (en) Antimicrobial formulations comprising a quinone and a copper salt
EP1874264A1 (en) Antimicrobial formulations
CN105338963A (zh) 用于减少痂形成并促进愈合的组合物
CN110420257A (zh) 一种复合奶牛乳头药浴液及其制备方法
US20070298150A1 (en) Food and beverage preservative
US9629913B2 (en) Silver oxide formulations
US12485142B2 (en) Silver oxide formulations
CN105596235A (zh) 一种新型奶牛乳头药浴液及其制备方法
JPH03157311A (ja) にきび用化粧料
KR102363112B1 (ko) 1,2-헥산디올과 글리세릴카프릴레이트를 포함하는 미생물 증식 억제용 조성물
CN108078810A (zh) 美白淡斑的皮肤护理化妆品组合物
KR20100121795A (ko) 비수계 화장품용 유용성 방부 대체제 조성물
WO2012103011A1 (en) Stable silver oxide formulations
KR20110058260A (ko) 화장료 조성물

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20150622

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251212

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-6-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260326

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260326